Revised SPC: Brilique (ticagrelor) products
electronic Medicines compendium
Timing of discontinuation of ticagrelor prior to elective surgery has been changed from 7 to 5 days.
Circulation
This review aims to provide a brief summary on physiology of haemostasis, review key studies on DOAC safety and efficacy in AF catheter ablation, and identify current gaps in knowledge on intraprocedural anticoagulation and monitoring.
The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at:
http://www.evidence.nhs.uk/about-evidence-services/content-and-sources/medicines-information/new-medicines-awareness-services